Abstract
Protein refolding is still on trial-and-error basis. Here we describe step-wise dialysis refolding, in which denaturant concentration is altered in step-wise fashion. This technology controls the folding pathway by adjusting the concentrations of the denaturant and other solvent additives to induce sequential folding or disulfide formation.
Keywords: Step-wise refolding, arginine, aggregation, antibody fragment, dialysis
Current Pharmaceutical Biotechnology
Title: Step-Wise Refolding of Recombinant Proteins
Volume: 11 Issue: 3
Author(s): Kouhei Tsumoto, Tsutomu Arakawa and Linda Chen
Affiliation:
Keywords: Step-wise refolding, arginine, aggregation, antibody fragment, dialysis
Abstract: Protein refolding is still on trial-and-error basis. Here we describe step-wise dialysis refolding, in which denaturant concentration is altered in step-wise fashion. This technology controls the folding pathway by adjusting the concentrations of the denaturant and other solvent additives to induce sequential folding or disulfide formation.
Export Options
About this article
Cite this article as:
Tsumoto Kouhei, Arakawa Tsutomu and Chen Linda, Step-Wise Refolding of Recombinant Proteins, Current Pharmaceutical Biotechnology 2010; 11 (3) . https://dx.doi.org/10.2174/138920110791111979
DOI https://dx.doi.org/10.2174/138920110791111979 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Neuropsychiatric Involvement in Systemic Lupus Erythematosus:Current Therapeutic Approach
Current Pharmaceutical Design Evaluation of Oxidative Status with Exhaled Breath 8-isoprostane Levels in Patients with Hyperthyroidism
Endocrine, Metabolic & Immune Disorders - Drug Targets DNA Damage Repair and Response Proteins as Targets for Cancer Therapy
Current Medicinal Chemistry Effect of the Phytochemical Agents against the SARS-CoV and Some of them Selected for Application to COVID-19: A Mini-Review
Current Pharmaceutical Biotechnology Biochemical Markers of Autoimmune Diseases of the Nervous System
Current Pharmaceutical Design Anti-Diabetic Compounds and their Patent Information: An Update
Recent Patents on Inflammation & Allergy Drug Discovery iPreny-PseAAC: Identify C-terminal Cysteine Prenylation Sites in Proteins by Incorporating Two Tiers of Sequence Couplings into PseAAC
Medicinal Chemistry Mif1: A Missing Link between the Unfolded Protein Response Pathway and ER-Associated Protein Degradation?
Current Protein & Peptide Science Stroke and Neuroinflamation: Role of Sexual Hormones
Current Pharmaceutical Design Hsp70 in Oncology
Recent Patents on DNA & Gene Sequences Anti-VEGF Anticancer Drugs: Mind the Hypertension
Recent Advances in Cardiovascular Drug Discovery (Discontinued) Specific Biologic Therapy with Tumor Necrosis Factor Inhibitors in Patients with Inflammatory Myopathy
Current Rheumatology Reviews Effects of Drug Transporters on Pharmacological Responses and Safety
Current Drug Metabolism Chemical Glycan Conjugation Controls the Biodistribution and Kinetics of Proteins in Live Animals
Mini-Reviews in Medicinal Chemistry Patent Selections
Recent Patents on Anti-Cancer Drug Discovery Effector Cells and Downstream Mediators in Severe Cutaneous Adverse Reactions
Current Immunology Reviews (Discontinued) Algal Toxins as Guidance to Identify Phosphoproteins with Key Roles inApoptotic Cell Death
Current Pharmaceutical Biotechnology The Resurgence of Aldosterone in Hypertension and Cardiovascular Disease
Current Hypertension Reviews Recent Patents on Topical Application of Honey in Wound and Burn Management
Recent Patents on Inflammation & Allergy Drug Discovery 1,2,4-Triazine Chemistry Part III: Synthetic Strategies to Functionalized Bridgehead Nitrogen Heteroannulated 1,2,4-Triazine Systems and their Regiospecific and Pharmacological Properties
Current Organic Synthesis